Featured Products

My Quote Request

No products added yet

6505-01-157-7622

20 Products

QUINAGLUTE

QUINIDINE GLUCONATE EXTENDED-RELEASE TABLETS

NSN, MFG P/N

6505011577622

NSN

6505-01-157-7622

View More Info

QUINAGLUTE

QUINIDINE GLUCONATE EXTENDED-RELEASE TABLETS

NSN, MFG P/N

6505011577622

NSN

6505-01-157-7622

MFG

BAYER HEALTHCARE PHARMACEUTICALS INC. DBA BERLICHEM

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 324.000 MILLIGRAMS QUINIDINE GLUCONATE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: LONG ACTION METHOD:EXTENDED RELEASE;SCORING CHARACTERISTICS:HALF-SCORED;

NDC00025-2068-30

NITROGLYCERIN TRANSDERMAL SYSTEM

NSN, MFG P/N

6505011579064

NSN

6505-01-157-9064

View More Info

NDC00025-2068-30

NITROGLYCERIN TRANSDERMAL SYSTEM

NSN, MFG P/N

6505011579064

NSN

6505-01-157-9064

MFG

ROBERTS PHARMACEUTICAL CORP

Description

FEATURES PROVIDED: MEMBRANE-PERMEATION CONTROLLED AND MEMBRANE-PARTITION CONTROLLED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NITROGLYCERIN TRANSDERMAL SYSTEM 30S
OVERALL STRENGTH IN SYSTEM: 32 MG NITROGLYCERIN ACTIVE INGREDIENT
SYSTEM SIZE: 16 SQUARE CENTIMETER
USUAL DOSE: 10 MG RELEASED PER 24 HOURS

NDC00085-3320-30

NITROGLYCERIN TRANSDERMAL SYSTEM

NSN, MFG P/N

6505011579064

NSN

6505-01-157-9064

View More Info

NDC00085-3320-30

NITROGLYCERIN TRANSDERMAL SYSTEM

NSN, MFG P/N

6505011579064

NSN

6505-01-157-9064

MFG

SCHERING-PLOUGH CORPORATION

Description

FEATURES PROVIDED: MEMBRANE-PERMEATION CONTROLLED AND MEMBRANE-PARTITION CONTROLLED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NITROGLYCERIN TRANSDERMAL SYSTEM 30S
OVERALL STRENGTH IN SYSTEM: 32 MG NITROGLYCERIN ACTIVE INGREDIENT
SYSTEM SIZE: 16 SQUARE CENTIMETER
USUAL DOSE: 10 MG RELEASED PER 24 HOURS

NDC00085-3320-35

NITROGLYCERIN TRANSDERMAL SYSTEM

NSN, MFG P/N

6505011579064

NSN

6505-01-157-9064

View More Info

NDC00085-3320-35

NITROGLYCERIN TRANSDERMAL SYSTEM

NSN, MFG P/N

6505011579064

NSN

6505-01-157-9064

MFG

SCHERING-PLOUGH CORPORATION

Description

FEATURES PROVIDED: MEMBRANE-PERMEATION CONTROLLED AND MEMBRANE-PARTITION CONTROLLED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NITROGLYCERIN TRANSDERMAL SYSTEM 30S
OVERALL STRENGTH IN SYSTEM: 32 MG NITROGLYCERIN ACTIVE INGREDIENT
SYSTEM SIZE: 16 SQUARE CENTIMETER
USUAL DOSE: 10 MG RELEASED PER 24 HOURS

NDC00089-0303-02

NITROGLYCERIN TRANSDERMAL SYSTEM

NSN, MFG P/N

6505011579064

NSN

6505-01-157-9064

View More Info

NDC00089-0303-02

NITROGLYCERIN TRANSDERMAL SYSTEM

NSN, MFG P/N

6505011579064

NSN

6505-01-157-9064

MFG

3M COMPANY HEALTH CARE/MFG

Description

FEATURES PROVIDED: MEMBRANE-PERMEATION CONTROLLED AND MEMBRANE-PARTITION CONTROLLED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NITROGLYCERIN TRANSDERMAL SYSTEM 30S
OVERALL STRENGTH IN SYSTEM: 32 MG NITROGLYCERIN ACTIVE INGREDIENT
SYSTEM SIZE: 16 SQUARE CENTIMETER
USUAL DOSE: 10 MG RELEASED PER 24 HOURS

NDC00089-1303-30

NITROGLYCERIN TRANSDERMAL SYSTEM

NSN, MFG P/N

6505011579064

NSN

6505-01-157-9064

View More Info

NDC00089-1303-30

NITROGLYCERIN TRANSDERMAL SYSTEM

NSN, MFG P/N

6505011579064

NSN

6505-01-157-9064

MFG

3M COMPANY HEALTH CARE/MFG

Description

FEATURES PROVIDED: MEMBRANE-PERMEATION CONTROLLED AND MEMBRANE-PARTITION CONTROLLED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NITROGLYCERIN TRANSDERMAL SYSTEM 30S
OVERALL STRENGTH IN SYSTEM: 32 MG NITROGLYCERIN ACTIVE INGREDIENT
SYSTEM SIZE: 16 SQUARE CENTIMETER
USUAL DOSE: 10 MG RELEASED PER 24 HOURS

NDC00378-9112-93

NITROGLYCERIN TRANSDERMAL SYSTEM

NSN, MFG P/N

6505011579064

NSN

6505-01-157-9064

View More Info

NDC00378-9112-93

NITROGLYCERIN TRANSDERMAL SYSTEM

NSN, MFG P/N

6505011579064

NSN

6505-01-157-9064

MFG

MYLAN PHARMACEUTICALS INC

Description

FEATURES PROVIDED: MEMBRANE-PERMEATION CONTROLLED AND MEMBRANE-PARTITION CONTROLLED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NITROGLYCERIN TRANSDERMAL SYSTEM 30S
OVERALL STRENGTH IN SYSTEM: 32 MG NITROGLYCERIN ACTIVE INGREDIENT
SYSTEM SIZE: 16 SQUARE CENTIMETER
USUAL DOSE: 10 MG RELEASED PER 24 HOURS

NDC00904-5496-46

NITROGLYCERIN TRANSDERMAL SYSTEM

NSN, MFG P/N

6505011579064

NSN

6505-01-157-9064

View More Info

NDC00904-5496-46

NITROGLYCERIN TRANSDERMAL SYSTEM

NSN, MFG P/N

6505011579064

NSN

6505-01-157-9064

MFG

MAJOR PHARMACEUTICALS INC

Description

FEATURES PROVIDED: MEMBRANE-PERMEATION CONTROLLED AND MEMBRANE-PARTITION CONTROLLED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NITROGLYCERIN TRANSDERMAL SYSTEM 30S
OVERALL STRENGTH IN SYSTEM: 32 MG NITROGLYCERIN ACTIVE INGREDIENT
SYSTEM SIZE: 16 SQUARE CENTIMETER
USUAL DOSE: 10 MG RELEASED PER 24 HOURS

NDC49730-0122-30

NITROGLYCERIN TRANSDERMAL SYSTEM

NSN, MFG P/N

6505011579064

NSN

6505-01-157-9064

View More Info

NDC49730-0122-30

NITROGLYCERIN TRANSDERMAL SYSTEM

NSN, MFG P/N

6505011579064

NSN

6505-01-157-9064

MFG

HERCON COMPANY INC

Description

FEATURES PROVIDED: MEMBRANE-PERMEATION CONTROLLED AND MEMBRANE-PARTITION CONTROLLED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NITROGLYCERIN TRANSDERMAL SYSTEM 30S
OVERALL STRENGTH IN SYSTEM: 32 MG NITROGLYCERIN ACTIVE INGREDIENT
SYSTEM SIZE: 16 SQUARE CENTIMETER
USUAL DOSE: 10 MG RELEASED PER 24 HOURS

NDC54092-0344-30

NITROGLYCERIN TRANSDERMAL SYSTEM

NSN, MFG P/N

6505011579064

NSN

6505-01-157-9064

View More Info

NDC54092-0344-30

NITROGLYCERIN TRANSDERMAL SYSTEM

NSN, MFG P/N

6505011579064

NSN

6505-01-157-9064

MFG

ROBERTS PHARMACEUTICAL CORP

Description

FEATURES PROVIDED: MEMBRANE-PERMEATION CONTROLLED AND MEMBRANE-PARTITION CONTROLLED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NITROGLYCERIN TRANSDERMAL SYSTEM 30S
OVERALL STRENGTH IN SYSTEM: 32 MG NITROGLYCERIN ACTIVE INGREDIENT
SYSTEM SIZE: 16 SQUARE CENTIMETER
USUAL DOSE: 10 MG RELEASED PER 24 HOURS

NDC62794-0204-93

NITROGLYCERIN TRANSDERMAL SYSTEM

NSN, MFG P/N

6505011579064

NSN

6505-01-157-9064

View More Info

NDC62794-0204-93

NITROGLYCERIN TRANSDERMAL SYSTEM

NSN, MFG P/N

6505011579064

NSN

6505-01-157-9064

MFG

MYLAN BERTEK PHARMACEUTICALS INC

Description

FEATURES PROVIDED: MEMBRANE-PERMEATION CONTROLLED AND MEMBRANE-PARTITION CONTROLLED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NITROGLYCERIN TRANSDERMAL SYSTEM 30S
OVERALL STRENGTH IN SYSTEM: 32 MG NITROGLYCERIN ACTIVE INGREDIENT
SYSTEM SIZE: 16 SQUARE CENTIMETER
USUAL DOSE: 10 MG RELEASED PER 24 HOURS

NITRODISC

NITROGLYCERIN TRANSDERMAL SYSTEM

NSN, MFG P/N

6505011579064

NSN

6505-01-157-9064

View More Info

NITRODISC

NITROGLYCERIN TRANSDERMAL SYSTEM

NSN, MFG P/N

6505011579064

NSN

6505-01-157-9064

MFG

ROBERTS PHARMACEUTICAL CORP

Description

FEATURES PROVIDED: MEMBRANE-PERMEATION CONTROLLED AND MEMBRANE-PARTITION CONTROLLED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NITROGLYCERIN TRANSDERMAL SYSTEM 30S
OVERALL STRENGTH IN SYSTEM: 32 MG NITROGLYCERIN ACTIVE INGREDIENT
SYSTEM SIZE: 16 SQUARE CENTIMETER
USUAL DOSE: 10 MG RELEASED PER 24 HOURS

NDC00025-2732-31

DISOPYRAMIDE PHOSPH

NSN, MFG P/N

6505011582170

NSN

6505-01-158-2170

View More Info

NDC00025-2732-31

DISOPYRAMIDE PHOSPH

NSN, MFG P/N

6505011582170

NSN

6505-01-158-2170

MFG

PHARMACIA & UPJOHN INC

Description

GENERAL CHARACTERISTICS ITEM DESCRIPTION: 100 MG DISOPYRAMIDE PHOSPHATE EQUIVALENT; 100 CAPSULES PER BOTTLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DISOPYRAMIDE PHOSPHATE EXTENDED-RELEASE CAPSULES 100MG 100S BT

NORPACE CR

DISOPYRAMIDE PHOSPH

NSN, MFG P/N

6505011582170

NSN

6505-01-158-2170

View More Info

NORPACE CR

DISOPYRAMIDE PHOSPH

NSN, MFG P/N

6505011582170

NSN

6505-01-158-2170

MFG

SEARLE G D AND CO

Description

GENERAL CHARACTERISTICS ITEM DESCRIPTION: 100 MG DISOPYRAMIDE PHOSPHATE EQUIVALENT; 100 CAPSULES PER BOTTLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DISOPYRAMIDE PHOSPHATE EXTENDED-RELEASE CAPSULES 100MG 100S BT

NORPACSE CR

DISOPYRAMIDE PHOSPH

NSN, MFG P/N

6505011582170

NSN

6505-01-158-2170

View More Info

NORPACSE CR

DISOPYRAMIDE PHOSPH

NSN, MFG P/N

6505011582170

NSN

6505-01-158-2170

MFG

PHARMACIA & UPJOHN INC

Description

GENERAL CHARACTERISTICS ITEM DESCRIPTION: 100 MG DISOPYRAMIDE PHOSPHATE EQUIVALENT; 100 CAPSULES PER BOTTLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DISOPYRAMIDE PHOSPHATE EXTENDED-RELEASE CAPSULES 100MG 100S BT

12-119-055

HEMODIALYSIS SOLUTION,CONCENTRATED

NSN, MFG P/N

6505011583297

NSN

6505-01-158-3297

View More Info

12-119-055

HEMODIALYSIS SOLUTION,CONCENTRATED

NSN, MFG P/N

6505011583297

NSN

6505-01-158-3297

MFG

COBE LABORATORIES INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIEQUIVALENTS ACETIC ACID PER LITER AND 3.000 MILLIEQUIVALENTS CALCIUM ION PER LITER AND 104.750 MILLIEQUIVALENTS CHLORIDE ION PER LITER AND 2.000 GRAMS DEXTROSE PER LITER AND 100.000 MILLIEQUIVALENTS SODIUM ION PER LITER AND 0.75 MEQ. MAGNESIUM
PRIMARY CONTAINER CONTENT QUANTITY: 55.000 GALLONS
PRIMARY CONTAINER TYPE: DRUM
SPECIAL FEATURES: STRENGTHS IN PAC AKJA ARE AFTER DILUTION OF 1 PART SOLUTION WITH 44 PARTS WATER; MUST BE USED WITH COBE LABS.,INC. PRODUCT NUMBER 17-002 ONLY ON COBE CENTRY DIALYSIS EQUIPMENT
~1: ION PER LITER AND 1 MEQ. POTASSIUM ION PER LITER

RENALYTE RX 119

HEMODIALYSIS SOLUTION,CONCENTRATED

NSN, MFG P/N

6505011583297

NSN

6505-01-158-3297

View More Info

RENALYTE RX 119

HEMODIALYSIS SOLUTION,CONCENTRATED

NSN, MFG P/N

6505011583297

NSN

6505-01-158-3297

MFG

COBE LABORATORIES INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIEQUIVALENTS ACETIC ACID PER LITER AND 3.000 MILLIEQUIVALENTS CALCIUM ION PER LITER AND 104.750 MILLIEQUIVALENTS CHLORIDE ION PER LITER AND 2.000 GRAMS DEXTROSE PER LITER AND 100.000 MILLIEQUIVALENTS SODIUM ION PER LITER AND 0.75 MEQ. MAGNESIUM
PRIMARY CONTAINER CONTENT QUANTITY: 55.000 GALLONS
PRIMARY CONTAINER TYPE: DRUM
SPECIAL FEATURES: STRENGTHS IN PAC AKJA ARE AFTER DILUTION OF 1 PART SOLUTION WITH 44 PARTS WATER; MUST BE USED WITH COBE LABS.,INC. PRODUCT NUMBER 17-002 ONLY ON COBE CENTRY DIALYSIS EQUIPMENT
~1: ION PER LITER AND 1 MEQ. POTASSIUM ION PER LITER

NDC00054-8707-25

PHENOBARBITAL TABLETS,USP

NSN, MFG P/N

6505011583628

NSN

6505-01-158-3628

View More Info

NDC00054-8707-25

PHENOBARBITAL TABLETS,USP

NSN, MFG P/N

6505011583628

NSN

6505-01-158-3628

MFG

BOEHRINGER INGELHEIM ROXANE INC. DIV SUB OF BOEHRINGER INGELHEIM CORP

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS PHENOBARBITAL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PHENOBARBITAL TABLETS USP 100MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE

NDC00603-5168-21

PHENOBARBITAL TABLETS,USP

NSN, MFG P/N

6505011583628

NSN

6505-01-158-3628

View More Info

NDC00603-5168-21

PHENOBARBITAL TABLETS,USP

NSN, MFG P/N

6505011583628

NSN

6505-01-158-3628

MFG

GENERICS BIDCO I LLC DBA QUALITEST PHARMACEUTICALS

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS PHENOBARBITAL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PHENOBARBITAL TABLETS USP 100MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE

NDC54868-3381-00

PHENOBARBITAL TABLETS,USP

NSN, MFG P/N

6505011583628

NSN

6505-01-158-3628

View More Info

NDC54868-3381-00

PHENOBARBITAL TABLETS,USP

NSN, MFG P/N

6505011583628

NSN

6505-01-158-3628

MFG

MEDICAL AND SAFETY GROUP INC DBA INDUSTRIAL DRUG SERVICE

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS PHENOBARBITAL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PHENOBARBITAL TABLETS USP 100MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE